#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Colorectal cancer Dementia Alzheimer's type Ovarian cancer Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Ovarian epithelial cancer Arterial disorder Partial lipodystrophy Peripheral primitive neuroectodermal tumour of soft tissue Chemical burn Neurofibroma Ectonucleotide pyrophosphatase/phosphodiesterase 1 deficiency Ventricular tachycardia Severe myoclonic epilepsy of infancy Anti-HLA antibody test positive Osteosarcoma Prader-Willi syndrome Oesophageal carcinoma Noonan syndrome Granulomatosis with polyangiitis More trials…

    Learn about Rare Diseases

    Burkitt’s lymphoma – Life with Disease Mantle cell lymphoma stage IV Fragile X syndrome – Treatment Haemophilia B with anti factor IX – Diagnostics Synovial sarcoma metastatic – Treatment Loeys-Dietz syndrome – Life with Disease Angiosarcoma – Trials in Disease Synovial sarcoma – Diagnostics Paraneoplastic neurological syndrome – Diagnostics Lysosomal storage disorder – Life with Disease More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Gsk4527226 ANHYDROUS CALCIUM FOLINATE [18F]Fapi-74 Calcitriol Faricimab Vusolimogene Oderparepvec Senicapoc Gen3017 Bay 3283142 L-METHIONINE Obeticholic Acid IPN01195 Plasma Setmelanotide Mycophenolate Sodium Befiradol (18F) Pimavanserin Tartrate Mercaptopurine Protease Amiloride More therapies…

    Learn about Your Condition

    Hereditary angioedema Post procedural swelling Abdominal wall pain Factor VIII deficiency Dementia with Lewy bodies Asymptomatic HIV infection Paresis Testis cancer Immune-mediated enterocolitis Breast angiosarcoma metastatic Hyperkalaemia Primary hyperaldosteronism Weaning failure Osteomyelitis acute Diabetic foot infection More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

Acute lymphocytic leukaemia

  • Study of Ziftomenib with Chemotherapy for Children with Relapsed or Refractory Acute Leukemia

    Recruiting

    1 1 1 1
    Investigated Diseases:
    • Acute myeloid leukaemia
    • Acute lymphocytic leukaemia
    Investigated Drugs:
    • Ziftomenib
    • Fludarabine Phosphate
    • Cytarabine
    Austria France Italy The Netherlands Spain

  • Long-term Safety Study of AUTO4 and Rituximab in Patients with Potential Malignancy Treated with Autologous CAR T Cell Therapy

    Recruiting

    2 1 1 1
    Investigated Diseases:
    • Non-Hodgkin’s lymphoma
    • Systemic lupus erythematosus
    • Acute lymphocytic leukaemia
    Investigated Drugs:
    • Auto4
    • Autologous Enriched T Cells Retrovirally Transduced To Express Two Chimeric Antigen Receptors Targeting Cd19 And Cd22
    • Rituximab
    Spain

  • Study Comparing Inotuzumab Ozogamicin to Drug Combination for Children with High-Risk Relapsed B-cell Acute Lymphoblastic Leukemia

    Recruiting

    2 1 1 1
    Investigated Drugs:
    • Mitoxantrone Hydrochloride
    • Dexamethasone Ph. Eur.
    • Inotuzumab Ozogamicin
    Austria Belgium Czechia Denmark Finland France +10

  • Study on the Safety and Effectiveness of Tafasitamab for Children with Relapsed or Refractory Acute B Lineage Leukemia

    Recruiting

    1 1 1 1
    Investigated Diseases:
    • Acute lymphocytic leukaemia
    Investigated Drugs:
    • Tafasitamab
    Germany

  • Study of Ruxolitinib and Venetoclax for Children with Relapsed or Refractory Leukemia or Lymphoma with IL-7R/JAK-STAT Pathway Mutations

    Recruiting

    1 1 1 1
    Investigated Diseases:
    • Precursor T-lymphoblastic lymphoma/leukaemia recurrent
    • Precursor T-lymphoblastic lymphoma/leukaemia refractory
    • Acute lymphocytic leukaemia
    Investigated Drugs:
    • Ruxolitinib
    • Venetoclax
    Austria Belgium Denmark Finland France Germany +5

  • Study on Ponatinib and Imatinib for Adults with Philadelphia-Chromosome Positive Acute Lymphoblastic Leukemia

    Recruiting

    2 1 1 1
    Investigated Diseases:
    • Acute lymphocytic leukaemia
    Investigated Drugs:
    • Ponatinib
    • Blinatumomab
    • Imatinib
    Germany
Previous Page
1 2 3 4 … 7
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!